Infection Analytics Program, Kirby Institute, The University of New South Wales, Kensington, NSW 2052, Australia.
Malaria Immunology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4006, Australia.
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):7701-7706. doi: 10.1073/pnas.1618939114. Epub 2017 Jul 3.
Severe malaria and associated high parasite burdens occur more frequently in humans lacking robust adaptive immunity to Nevertheless, the host may partly control blood-stage parasite numbers while adaptive immunity is gradually established. Parasite control has typically been attributed to enhanced removal of parasites by the host, although in vivo quantification of this phenomenon remains challenging. We used a unique in vivo approach to determine the fate of a single cohort of semisynchronous, ANKA- or 17XNL-parasitized red blood cells (pRBCs) after transfusion into naive or acutely infected mice. As previously shown, acutely infected mice, with ongoing splenic and systemic inflammatory responses, controlled parasite population growth more effectively than naive controls. Surprisingly, however, this was not associated with accelerated removal of pRBCs from circulation. Instead, transfused pRBCs remained in circulation longer in acutely infected mice. Flow cytometric assessment and mathematical modeling of intraerythrocytic parasite development revealed an unexpected and substantial slowing of parasite maturation in acutely infected mice, extending the life cycle from 24 h to 40 h. Importantly, impaired parasite maturation was the major contributor to control of parasite growth in acutely infected mice. Moreover, by performing the same experiments in mice, which lack T and B cells and mount weak inflammatory responses, we revealed that impaired parasite maturation is largely dependent upon the host response to infection. Thus, impairment of parasite maturation represents a host-mediated, immune system-dependent mechanism for limiting parasite population growth during the early stages of an acute blood-stage infection.
严重疟疾和相关的高寄生虫负担在缺乏对寄生虫有效适应性免疫的人类中更为常见。然而,在适应性免疫逐渐建立的过程中,宿主可能会部分控制血阶段寄生虫数量。寄生虫的控制通常归因于宿主增强了对寄生虫的清除,尽管体内定量这种现象仍然具有挑战性。我们使用一种独特的体内方法来确定在输入到幼稚或急性感染的小鼠后,单个批次半同步、ANKA 或 17XNL 寄生虫化的红细胞 (pRBC) 的命运。如前所示,急性感染的小鼠,伴有持续的脾脏和全身炎症反应,比幼稚对照组更有效地控制寄生虫种群的增长。然而,令人惊讶的是,这与从循环中加速清除 pRBC 无关。相反,输入的 pRBC 在急性感染的小鼠中在循环中停留的时间更长。对红细胞内寄生虫发育的流式细胞术评估和数学建模揭示了急性感染小鼠中寄生虫成熟的意外和实质性减缓,将生命周期从 24 小时延长至 40 小时。重要的是,寄生虫成熟受损是急性感染小鼠控制寄生虫生长的主要原因。此外,通过在缺乏 T 和 B 细胞且炎症反应较弱的 小鼠中进行相同的实验,我们揭示了寄生虫成熟受损在很大程度上取决于宿主对感染的反应。因此,寄生虫成熟受损代表了宿主介导的、免疫系统依赖的机制,可在急性血期寄生虫感染的早期阶段限制寄生虫种群的增长。